22nd Century Group (XXII) Adds 1,200 Drug Store Locations Selling VLN® in Five States
September 12, 2023 07:00 ET
|
22nd Century Group, Inc
BUFFALO, N.Y., Sept. 12, 2023 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a leading biotechnology company focused on utilizing advanced plant technologies to improve health and...
22nd Century Group Initiates Strategic Alternatives Process for Its Tobacco Assets
September 05, 2023 07:00 ET
|
22nd Century Group, Inc
BUFFALO, N.Y., Sept. 05, 2023 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (NASDAQ: XXII) (the “Company”) today announced that its Board of Directors, after consultation with its financial and legal...
22nd Century Group (XXII) Reports Second Quarter 2023 Financial Results
August 14, 2023 06:00 ET
|
22nd Century Group, Inc
Second Quarter 2023 Net Revenues Increased 62% to $23.4 MillionLaunched VLN® Sales in California, Texas and FloridaDelivered Record GVB Ingredient Volumes as Dominant Supplier in North...
22nd Century Group (XXII) Updates Second Quarter 2023 Results Webcast Time on August 14, 2023
August 09, 2023 08:00 ET
|
22nd Century Group, Inc
BUFFALO, N.Y., Aug. 09, 2023 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a leading biotechnology company dedicated to improving health with reduced nicotine tobacco, hemp/cannabis...
22nd Century Group (Nasdaq: XXII) to Announce Second Quarter 2023 Results on August 14, 2023
August 07, 2023 08:00 ET
|
22nd Century Group, Inc
BUFFALO, N.Y., Aug. 07, 2023 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a leading biotechnology company dedicated to improving health with reduced nicotine tobacco, hemp/cannabis...
22nd Century Announces Executive Leadership Changes
July 24, 2023 09:20 ET
|
22nd Century Group, Inc
Expands Board with New Highly Accomplished Independent Director Strengthens Balance Sheet and Implements $15 Million Cost Reduction Initiative BUFFALO, N.Y., July 24, 2023 (GLOBE...
22nd Century Group (XXII) Regains Compliance with Nasdaq Listing Standards
July 20, 2023 09:20 ET
|
22nd Century Group, Inc
BUFFALO, N.Y., July 20, 2023 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a leading biotechnology company focused on utilizing advanced plant technologies to improve health and...
A Cigarette to Help Californians Smoke Less: 22nd Century Group, Inc. Launches Reduced Nicotine VLN® King Cigarettes in California, VLN Will Be Sold at #1 U.S. Convenience Store Chain and Other Responsible Retail Locations
July 17, 2023 09:20 ET
|
22nd Century Group, Inc
SACRAMENTO, Calif., July 17, 2023 (GLOBE NEWSWIRE) -- Biotech company 22nd Century Group, Inc. (NASDAQ: XXII) this week launched VLN® King cigarettes, the first-ever reduced nicotine combustible...
22nd Century Group (XXII) VLN® Products Now Selling in Montana C-Stores
July 13, 2023 08:40 ET
|
22nd Century Group, Inc
Town Pump, #1 Chain in Montana, Selling VLN® Products in More Than 80 Stores Across the State Broad Availability of VLN® Expands Access to New Tool to Reduce the Harms of Smoking BUFFALO, N.Y., July...
22nd Century Group (XXII) Announces New Agreement with Hub, Inc. to Expand Midwest Distribution
July 12, 2023 08:35 ET
|
22nd Century Group, Inc
BUFFALO, N.Y., July 12, 2023 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a leading biotechnology company focused on utilizing advanced plant technologies to improve health and...